ENTRADA THERAPEUTICS
Live / Registered — Registered (as of 17 Jan 2023)
What this means for you
Registered since 17 Jan 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Jan 2029: the §8 declaration of use).
Record
- Serial number
- 87627637
- Registration number
- 6957830
- Mark type
- Word mark
- Filed
- 29 Sept 2017
- Published for opposition
- 18 Sept 2018
- Registered
- 17 Jan 2023
- Next maintenance filing
- §8 declaration of use, due by 17 Jan 2029 (grace period to 17 Jul 2029)
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: House mark for a line of pharmaceuticals, but not including pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis, all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer
Owner
- ENTRADA THERAPEUTICS, INC., Boston, MA, US
- ENTRADA THERAPEUTICS, INC., Boston, MA, US
- ENTRADA THERAPEUTICS, INC., BOSTON, MA, US
- CycloPorters, Inc., Boston, MA, US
Board proceedings on this mark
- Opposition No. 91244410 — Genzyme Corporation v. Entrada Therapeutics, Inc., filed 26 Oct 2018 (Terminated)
- Extension of Time to Oppose No. 87627637 — Cephalon, Inc. v. ENTRADA THERAPEUTICS, INC., filed 09 Oct 2018 (Terminated)
Prosecution history
- 24 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Nov 2022 — USE AMENDMENT FILED
- 28 Nov 2022 — TEAS STATEMENT OF USE RECEIVED
- 21 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2022 — SOU EXTENSION 5 GRANTED
- 14 Apr 2022 — SOU EXTENSION 5 FILED